Daniel Pettitt

727 total citations
15 papers, 585 citations indexed

About

Daniel Pettitt is a scholar working on Surgery, Pharmacology and Economics and Econometrics. According to data from OpenAlex, Daniel Pettitt has authored 15 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 4 papers in Pharmacology and 4 papers in Economics and Econometrics. Recurrent topics in Daniel Pettitt's work include Health Systems, Economic Evaluations, Quality of Life (4 papers), Inflammatory mediators and NSAID effects (4 papers) and Lipoproteins and Cardiovascular Health (4 papers). Daniel Pettitt is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (4 papers), Inflammatory mediators and NSAID effects (4 papers) and Lipoproteins and Cardiovascular Health (4 papers). Daniel Pettitt collaborates with scholars based in United States, United Kingdom and Canada. Daniel Pettitt's co-authors include Alistair McGuire, J. Jaime, Wendy S. Klittich, John Norrie, J. Shepherd, Ian Ford, John J.V. McMurray, Andrew J. Karter, Joe V. Selby and Douglas C. Bauer and has published in prestigious journals such as Annals of Internal Medicine, Gastroenterology and Journal of the American College of Cardiology.

In The Last Decade

Daniel Pettitt

15 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Pettitt United States 10 218 191 104 104 79 15 585
Unchalee Permsuwan Thailand 16 166 0.8× 93 0.5× 276 2.7× 144 1.4× 48 0.6× 66 788
Elizabeth Marrett United States 14 162 0.7× 190 1.0× 133 1.3× 243 2.3× 23 0.3× 29 642
Curt D. Furberg United States 12 214 1.0× 324 1.7× 423 4.1× 160 1.5× 45 0.6× 16 964
Stefano Buda Italy 14 185 0.8× 153 0.8× 426 4.1× 158 1.5× 46 0.6× 65 858
Ezio Degli Esposti Italy 12 170 0.8× 114 0.6× 417 4.0× 109 1.0× 27 0.3× 47 688
Andrew Weekes Australia 11 94 0.4× 81 0.4× 156 1.5× 216 2.1× 98 1.2× 22 716
Magdalena Rosell Spain 8 98 0.4× 180 0.9× 201 1.9× 285 2.7× 29 0.4× 10 953
Klas Bergenheim Sweden 19 152 0.7× 141 0.7× 136 1.3× 678 6.5× 51 0.6× 50 851
Eni C. Okonofua United States 10 119 0.5× 143 0.7× 380 3.7× 160 1.5× 23 0.3× 10 794
Ammar Jesri United States 5 100 0.5× 106 0.6× 400 3.8× 123 1.2× 23 0.3× 5 674

Countries citing papers authored by Daniel Pettitt

Since Specialization
Citations

This map shows the geographic impact of Daniel Pettitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Pettitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Pettitt more than expected).

Fields of papers citing papers by Daniel Pettitt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Pettitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Pettitt. The network helps show where Daniel Pettitt may publish in the future.

Co-authorship network of co-authors of Daniel Pettitt

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Pettitt. A scholar is included among the top collaborators of Daniel Pettitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Pettitt. Daniel Pettitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Schembri, Stuart, William J. Anderson, S. V. Morant, et al.. (2009). A predictive model of hospitalisation and death from chronic obstructive pulmonary disease. Respiratory Medicine. 103(10). 1461–1467. 48 indexed citations
2.
Walker, Alexander M., et al.. (2006). Anemia as a Predictor of Cardiovascular Events in Patients with Elevated Serum Creatinine. Journal of the American Society of Nephrology. 17(8). 2293–2298. 60 indexed citations
3.
Rodondi, Nicolas, Tiffany Peng, Andrew J. Karter, et al.. (2006). Therapy Modifications in Response to Poorly Controlled Hypertension, Dyslipidemia, and Diabetes Mellitus. Annals of Internal Medicine. 144(7). 475–484. 162 indexed citations
4.
Schwartz, Jean-Charles, et al.. (2003). Adherence to chronic therapy among patients treated for hypertension, dyslipidemia, or both. Journal of the American College of Cardiology. 41(6). 526–526. 7 indexed citations
6.
Pettitt, Daniel, et al.. (2001). The effect of nonsteroidal anti-inflammatory drugs on the use of gastroprotective medication in people with arthritis.. PubMed. 7(4). 402–8. 13 indexed citations
7.
Pettitt, Daniel, Jay L. Goldstein, Andrew McGuire, et al.. (2000). Overview of the Arthritis Cost Consequence Evaluation System (ACCES). Lara D. Veeken. 39(suppl_2). 33–42. 27 indexed citations
8.
Goldstein, Jay L., et al.. (2000). Development of a scoring system for predicting upper gastrointestinal distress. Gastroenterology. 118(4). A249–A249. 2 indexed citations
9.
Pettitt, Daniel. (2000). Determinants of cycloxygenase (COX)-2 specific inhibitor utilization in a managed care population. The American Journal of Gastroenterology. 95(9). 2637–2638. 1 indexed citations
10.
Ilic, Sanja, Lois Jovanovič, & Daniel Pettitt. (1999). Comparison of the Effect of Saturated and Monounsaturated Fat on Postprandial Plasma Glucose and Insulin Concentration in Women with Gestational Diabetes Mellitus. American Journal of Perinatology. 16(9). 489–496. 21 indexed citations
11.
Jaime, J., Wendy S. Klittich, Alistair McGuire, et al.. (1997). The cost-effectiveness of preventing initial coronary events with pravastatin. Atherosclerosis. 134. 46–46. 3 indexed citations
12.
Jaime, J., Wendy S. Klittich, Alistair McGuire, et al.. (1997). The West of Scotland coronary prevention study: economic benefit analysis of primary prevention with pravastatin. BMJ. 315(7122). 1577–1582. 158 indexed citations
13.
Morris, Stephen, Alistair McGuire, J. Jaime, & Daniel Pettitt. (1997). Strategies for the Management of Hypercholesterolaemia: A Systematic Review of the Cost-Effectiveness Literature. Journal of Health Services Research & Policy. 2(4). 231–250. 21 indexed citations
14.
Jaime, J., Wendy S. Klittich, Alistair McGuire, et al.. (1997). 1.P.139 The cost-effectiveness of preventing initial coronary events with pravastatin: Results of the West of Scotland coronary prevention study economic analysis. Atherosclerosis. 134(1-2). 46–46. 4 indexed citations
15.
Covens, Allan, et al.. (1996). Is paclitaxel and cisplatin a cost-effective first-line therapy for advanced ovarian carcinoma?. Cancer. 77(10). 2086–2091. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026